China · Delayed Price · Currency is CNY BGI Genomics Company Description
BGI Genomics Co., Ltd. engages in the provision of genomic sequencing services and proteomic services to academic institutions, pharmaceutical companies, health care providers and other organizations in China and internationally.
The company offers DNA sequencing services covering whole genome sequencing, plant/animal whole genome sequencing, exome sequencing, de novo sequencing, and metagenomic sequencing; and mass spectrometry services, such as proteomic services and biologics characterization services.
It also provides diagnostics and precision medicine, such as COVID-19 solutions, partnership opportunities, infectious diseases, and oncology services.
The company was formerly known as Shenzhen BGI Medicine Co., Ltd. and changed its name to BGI Genomics Co., Ltd. in 2015.
The company was founded in 1999 and is headquartered in Shenzhen, China. BGI Genomics Co., Ltd. operates as a subsidiary of BGI Group.
| Country | China |
| Founded | 1999 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 3,702 |
| CEO | Lijian Zhao |
Contact Details
Address: Building NO.7 Shenzhen, 518083 China | |
| Phone | 86 400 706 6615 |
| Website | bgi.com |
Stock Details
| Ticker Symbol | 300676 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100003449 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Lijian Zhao | GM and Director |
| Yujue Wang | Chief Financial Officer, Deputy GM and Non Independent Director |
| Qian Xu | Director of Legal Affairs, General Counsel, Deputy GM and Secretary |
| Hao Li | Deputy GM and Head of Marketing Center and i99 Division |
| Ning Li | Non Independent Director and Deputy GM |
| Shida Zhu | Deputy GM and Non Independent Director |
| Hui Liu | Head of the accounting department and Accounting Supervisor |
| Yun Yang Ph.D. | Deputy General Manager |
| Weijun Chen | Deputy General Manager |